External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Cardiovascular ESH 2024
Roche and Genentech at

ESH 2024

May 31 - June 03
Berlin, Germany
esh.eu
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
12:10 PM
Duration 5mins Berlin, Germany
Poster: KARDIA-3 Study Design: Zilebesiran As Add-On Therapy In Patients With High Cardiovascular Risk And Hypertension Inadequately Controlled By Standard Of Care Antihypertensives
Andrea Havasi, Neha Pagidipati, George Bakris, Michael Weber, Monica Bengus, Shruti Daga, Zhihua Xiang, Tiffany Zee1, Ishir Bhan1, Christopher B. Granger2
Cardiovascular | Hypertension

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 5mins Berlin, Germany
Graphical Abstract: KARDIA-3 Study Design: Zilebesiran as Add-On Therapy in Patients with High Cardiovascular Risk and Hypertension Inadequately Controlled by Standard of Care Antihypertensives
Andrea Havasi, Neha Pagidipati, George Bakris, Michael Weber, Monica Bengus, Shruti Daga, Zhihua Xiang, Tiffany Zee1, Ishir Bhan1, Christopher B. Granger2
Cardiovascular | Hypertension

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
12:30 PM
Duration 5mins Berlin, Germany
Poster: Zilebesiran As Add-On Therapy In Patients With Hypertension Inadequately Controlled With A Standard Antihypertensive Medication: Efficacy And Safety Results From The KARDIA-2 Study
Manish Saxena, Ahmad Aswad, Jolita Badariene, Farhana Kazi, Adam D Karns, Joel M Neutel, Wansu Park, Daniel Stiglitz, Nune Makarova, Andrea Havasi, Dion Zappe, George Bakris
Cardiovascular | Hypertension

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 5mins Berlin, Germany
Graphical Abstract: Zilebesiran As Add-On Therapy In Patients With Hypertension Inadequately Controlled With A Standard Antihypertensive Medication: Efficacy And Safety Results From The KARDIA-2 Study
Manish Saxena, Ahmad Aswad, Jolita Badariene, Farhana Kazi, Adam D Karns, Joel M Neutel, Wansu Park, Daniel Stiglitz, Nune Makarova, Andrea Havasi, Dion Zappe, George Bakris
Cardiovascular | Hypertension

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.